Evidence map›Paper›PMID 38607551›Full record

ArticleAmerican journal of respiratory and critical care medicine2024

Application of the European Respiratory Society/American Thoracic Society Spirometry Standards and Race-Neutral Equations in the COPDGene Study.

Enrico Schiavi, Min Hyung Ryu, Leonardo Martini, Aparna Balasubramanian, Meredith C McCormack, Spyridon Fortis, Elizabeth A Regan, Matteo Bonini, Craig P Hersh

Abstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Cardiovascular and Functional Consequences of Lung Function Impairment in Northern Thai Agricultural Workers.International journal of environmental research and public health · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Race-NeutralAmerican journal of respiratory and critical care medicine · 2024
    Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Enrico SchiaviDepartment of Cardiovascular and Pulmonary Sciences, Università Cattolica del Sacro Cuore, Rome, Italy.ORCID 0009-0003-3954-8620
Min Hyung RyuChanning Division of Network Medicine and.ORCID 0000-0003-3071-7363
Leonardo MartiniChanning Division of Network Medicine and.
Aparna BalasubramanianPulmonary and Critical Care, Johns Hopkins University School of Medicine, Baltimore, Maryland.ORCID 0000-0002-1854-6672
Meredith C McCormackPulmonary and Critical Care, Johns Hopkins University School of Medicine, Baltimore, Maryland.ORCID 0000-0003-1702-3201
Spyridon FortisCenter for Access and Delivery Research and Evaluation and Iowa City Veterans Affairs Healthcare System, University of Iowa Hospitals and Clinics, Iowa City, Iowa.ORCID 0000-0001-7807-6740
Elizabeth A ReganDepartment of Medicine, National Jewish Health, Denver, Colorado; and.
Matteo BoniniDepartment of Cardiovascular and Pulmonary Sciences, Università Cattolica del Sacro Cuore, Rome, Italy.
Craig P HershChanning Division of Network Medicine and.ORCID 0000-0002-1342-4334

Funding

Genetic Epidemiology of COPDU01HL089897 · NHLBI · NATIONAL JEWISH HEALTH · PI CRAPO, JAMES D · 2007 to 2021
$56.9M
GENETIC EPIDEMIOLOGY OF COPD (COPD GENE) TASK A: STUDY VISIT 4, COLLECTION OF COPDGENE STUDY DATA ANDBIOSPECIMENS AND OVERSIGHT OF THE COPDGENE STUDY75N92023D00011 · NHLBI · NATIONAL JEWISH HEALTH · PI NEWMAN, LEE S · 2023 to 2025
$29.6M
Genetic Epidemiology of COPDU01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2007 to 2021
$20.7M
Pulmonary Vascular Disease as a Contributor to Respiratory Morbidity in Chronic Obstructive Pulmonary DiseaseK23HL153778 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Aparna Balasubramanian · 2022 to 2026
$991k
Preclinical Services for Biopharmaceutical Product Development75N93023D00011 · NIAID · ALLUCENT GOVERNMENT SERVICES (US) LLC · 2023 to 2023
$7k
CLC NIH HHS 75N90023D00011NHLBI NIH HHS 75N92021D00011NHLBI NIH HHS 75N92023D00011NHLBI NIH HHS K23 HL153778NHLBI NIH HHS U01 HL089856NHLBI NIH HHS U01 HL089897NIAID NIH HHS 75N93023D00011
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Pulmonary Disease, Chronic ObstructiveSeverity of Illness IndexSocieties, MedicalSpirometryAgedEuropeFemaleForced Expiratory VolumeHumansMaleMiddle AgedUnited StatesCOPDethnicitypulmonary function testssurvival analysis

Identifiers

PMID38607551
PMCPMC11622435

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.